Literature DB >> 22150332

Aptamer selection by high-throughput sequencing and informatic analysis.

Shawn Hoon1, Bin Zhou, Kim D Janda, Sydney Brenner, Jonathan Scolnick.   

Abstract

Traditional methods for selecting aptamers require multiple rounds of selection and optimization in order to identify aptamers that bind with high affinity to their targets. Here we describe an assay that requires only one round of positive selection followed by high-throughput DNA sequencing and informatic analysis in order to select high-affinity aptamers. The assay is flexible, requires less hands on time, and can be used by laboratories with minimal expertise in aptamer biology to quickly select high-affinity aptamers to a target of interest. This assay has been utilized to successfully identify aptamers that bind to thrombin with dissociation constants in the nanomolar range.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22150332     DOI: 10.2144/000113786

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  33 in total

1.  Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery.

Authors:  Jan Hoinka; Alexey Berezhnoy; Phuong Dao; Zuben E Sauna; Eli Gilboa; Teresa M Przytycka
Journal:  Nucleic Acids Res       Date:  2015-04-13       Impact factor: 16.971

Review 2.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

3.  The selection of DNA aptamers for two different epitopes of thrombin was not due to different partitioning methods.

Authors:  Robert Wilson; Andrew Cossins; Dan V Nicolau; Sotiris Missailidis
Journal:  Nucleic Acid Ther       Date:  2012-12-05       Impact factor: 5.486

Review 4.  Library construction for next-generation sequencing: overviews and challenges.

Authors:  Steven R Head; H Kiyomi Komori; Sarah A LaMere; Thomas Whisenant; Filip Van Nieuwerburgh; Daniel R Salomon; Phillip Ordoukhanian
Journal:  Biotechniques       Date:  2014-02-01       Impact factor: 1.993

5.  Application of the Open qPCR Instrument for the in Vitro Selection of DNA Aptamers against Epidermal Growth Factor Receptor and Drosophila C Virus.

Authors:  Tulsi Ram Damase; Tanya A Miura; Christine E Parent; Peter B Allen
Journal:  ACS Comb Sci       Date:  2018-01-17       Impact factor: 3.784

Review 6.  Aptamers as targeted therapeutics: current potential and challenges.

Authors:  Jiehua Zhou; John Rossi
Journal:  Nat Rev Drug Discov       Date:  2016-11-03       Impact factor: 84.694

7.  Selection and Application of Aptamer Affinity for Protein Purification.

Authors:  Ana Paula de Jesus Santos; Ágatha Oliveira-Giacomelli; Vanessa Karen de Sá; Isis Cristina do Nascimento; Erika de Simone Molina; Henning Ulrich
Journal:  Methods Mol Biol       Date:  2022

8.  Single-round, multiplexed antibody mimetic design through mRNA display.

Authors:  C Anders Olson; Jeff Nie; Jonathan Diep; Ibrahim Al-Shyoukh; Terry T Takahashi; Laith Q Al-Mawsawi; Jennifer M Bolin; Angela L Elwell; Scott Swanson; Ron Stewart; James A Thomson; H Tom Soh; Richard W Roberts; Ren Sun
Journal:  Angew Chem Int Ed Engl       Date:  2012-11-04       Impact factor: 15.336

9.  Quantitative selection and parallel characterization of aptamers.

Authors:  Minseon Cho; Seung Soo Oh; Jeff Nie; Ron Stewart; Michael Eisenstein; James Chambers; Jamey D Marth; Faye Walker; James A Thomson; H Tom Soh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

Review 10.  Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Authors:  Yi Shu; Fengmei Pi; Ashwani Sharma; Mehdi Rajabi; Farzin Haque; Dan Shu; Markos Leggas; B Mark Evers; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.